| |
Remark |
|
|
 G Protein-coupled receptors
|
Rhodopsin family
|
 Acetylcholine (muscarinic)
|
Adrenaline
|
Dopamine
|
Histamine
|
H1-receptor [HSA:3269] [KO:K04149]
|
Ketanserin [ATC:C02KD01]
|
Thonzylamine [ATC:D04AA01 R01AC06 R06AC06]
|
Mepyramine [ATC:D04AA02 R06AC01]
|
Tripelennamine [ATC:D04AA04]
|
Promethazine [ATC:D04AA10 R06AD02]
|
Dimetindene [ATC:D04AA13 R06AB03]
|
Clemastine [ATC:D04AA14 R06AA04]
|
Bamipine [ATC:D04AA15 R06AX01]
|
Isothipendyl [ATC:D04AA22 R06AD09]
|
Diphenhydramine [ATC:D04AA32 R06AA02]
|
Chlorphenoxamine [ATC:D04AA34 R06AA06]
|
Dimetotiazine [ATC:N02CX05]
|
Chlorpromazine [ATC:N05AA01]
|
Olanzapine [ATC:N05AH03]
|
Quetiapine [ATC:N05AH04]
|
Hydroxyzine [ATC:N05BB01]
|
Opipramol [ATC:N06AA05]
|
Betahistine [ATC:N07CA01]
|
Cinnarizine [ATC:N07CA02]
|
Levocabastine [ATC:R01AC02 S01GX02]
|
Azelastine [ATC:R01AC03 R06AX19 S01GX07]
|
 D07483 Azelastine (INN)
D00659 Azelastine hydrochloride (JP16/USAN)
|
Antagonist
Antagonist
|
Antazoline [ATC:R01AC04 R06AX05]
|
Olopatadine [ATC:R01AC08 S01GX09]
|
Diphenylpyraline [ATC:R06AA07]
|
Carbinoxamine [ATC:R06AA08]
|
Doxylamine [ATC:R06AA09]
|
Brompheniramine [ATC:R06AB01]
|
Dexchlorpheniramine [ATC:R06AB02]
|
Chlorphenamine [ATC:R06AB04]
|
Pheniramine [ATC:R06AB05]
|
Dexbrompheniramine [ATC:R06AB06]
|
Alimemazine [ATC:R06AD01]
|
Mequitazine [ATC:R06AD07]
|
Cyclizine [ATC:R06AE03]
|
Meclozine [ATC:R06AE05]
|
Oxatomide [ATC:R06AE06]
|
Cetirizine [ATC:R06AE07]
|
Levocetirizine [ATC:R06AE09]
|
Cyproheptadine [ATC:R06AX02]
|
Phenindamine [ATC:R06AX04]
|
Triprolidine [ATC:R06AX07]
|
Azatadine [ATC:R06AX09]
|
Astemizole [ATC:R06AX11]
|
Terfenadine [ATC:R06AX12]
|
Loratadine [ATC:R06AX13]
|
Ketotifen [ATC:R06AX17 S01GX08]
|
Acrivastine [ATC:R06AX18]
|
Ebastine [ATC:R06AX22]
|
Epinastine [ATC:R06AX24]
|
Fexofenadine [ATC:R06AX26]
|
Desloratadine [ATC:R06AX27]
|
Rupatadine [ATC:R06AX28]
|
Bilastine [ATC:R06AX29]
|
Emedastine [ATC:S01GX06]
|
Alcaftadine
|
Bepotastine
|
Dimenhydrinate
|
Dioxopromethazine
|
Histamine
|
Homochlorcyclizine
|
Icotidine
|
Mizolastine
|
Noberastine
|
Rocastine
|
Tecastemizole
|
Temelastine
|
H2-receptor [HSA:3274] [KO:K04150]
|
H3-receptor [HSA:11255] [KO:K04151]
|
H4-receptor [HSA:59340] [KO:K04152]
|
Serotonin
|
Tachykinin / neurokinin
|
Ghrelin
|
Orexin
|
Neuropeptide Y
|
Opioid
|
Angiotensin
|
Bradykinin
|
Endothelin
|
Lutropin-choriogonadotropic hormone
|
Follicle stimulating hormone
|
Oxytocin
|
Vasopressin
|
Melanocortin
|
Gonadotropin-releasing hormone
|
Somatostatin
|
Thyrotropin-releasing hormone
|
Cholecystokinin
|
Motilin
|
Thrombin
|
Purine / pyrimidine
|
Adenosine
|
Prostaglandin
|
Prostacyclin
|
Leukotriene
|
Thromboxane
|
Sphingolipid
|
Free fatty acid
|
Cannabinoid
|
Platelet activating factor
|
Melatonin
|
Cysteinyl leukotriene
|
Secretin receptor family
|
Metabotropic glutamate receptor family
|
Others
|
|
|
Cytokine receptors
|
|
|
Nuclear receptors
|
|
|
Ion channels
|
|
|
Transporters
|
|
|
Enzymes
|
|
|
Protein kinases
|
|
|
Cytokines
|
|
|
Others
|
Target-based Classification of Drugs